COMMUNIQUÉS West-GlobeNewswire

New Genome BC Funded Project Aims to Bring BC Closer to Ending HIV Transmission
01/12/2025
VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- World AIDS Day 2025 — British Columbia has made remarkable progress in reducing HIV transmission and researchers now believe the province is closer than [...]
€150 million agreement between EIB and Angelini Ventures to finance European startups
01/12/2025
This is the first agreement signed by the EIB with a corporate venture capital in the healthcare sector, and is part of the EU strategy to support the development of innovative companies across the continent. Angelini [...]
REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025
01/12/2025
Press release – No. 17 / 2025 REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company [...]
BioNTX Concludes Landmark iC³® 2025 Summit — Announces 2026 Summit in Arlington, Texas
01/12/2025
DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The 2025 iC³® Life Science & Healthcare Innovation Summit, hosted by BioNTX , concluded on September 16–17 at the Hilton Anatole in Dallas, marking more than a decade of [...]
Hapbee Delivers Record Profit of USD $1.43 Million in Second Straight Quarter of Growth, Posts Q3 Revenue of $446,897 and Earnings of 0.5 Cents Per Share
01/12/2025
Record-setting financial performance driven by new management team grows recurring revenue position with 188% subscriber growth since Q1, reducing liabilities while advancing investments into Hapbee’s next-generation [...]
Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
01/12/2025
Results obtained in the Phase 2 placebo-controlled CLEAR-MIND clinical trial showed that treatment with stem cell therapy laromestrocel was associated with a reduction in MRI measured neuroinflammation compared to [...]
Plus Therapeutics to Present ReSPECT Phase 1 Dose Escalation Study Results for Leptomeningeal Metastases at the 2025 San Antonio Breast Cancer Symposium
01/12/2025
Study findings to be featured in a poster spotlight presentation HOUSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/12/2025
CLEVELAND, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
01/12/2025
New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with Dravet syndrome treated with zorevunersen support the potential for disease [...]
Altimmune Announces CEO Transition and Succession Plan
01/12/2025
Jerry Durso, accomplished industry leader, to succeed Vipin Garg, Ph.D. as Chief Executive Officer Transition follows seven years of strong leadership by Dr. Garg GAITHERSBURG, Md., Dec. 01, 2025 (GLOBE NEWSWIRE) -- [...]
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025
01/12/2025
Company to host a conference call and webcast on Saturday, December 6, 2025, at 8:00 pm ET SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a [...]
Tectonic Therapeutic to Participate in December Investor Conferences
01/12/2025
WATERTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic , Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
01/12/2025
KUALA LUMPUR, Malaysia and SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC”) today announced that it has executed an Exclusive Intellectual Property License Agreement for Southeast Asia with [...]
Sutro Biopharma Announces 1-for-10 Reverse Stock Split
01/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug [...]
Catheter Precision Announces Launch of LockeT in Switzerland
01/12/2025
Fort Mill, SC, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
01/12/2025
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world [...]
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
01/12/2025
Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP 3 ACT™ platform, show excellent in silico free energy binding to the viral target entry protein, supporting [...]
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
01/12/2025
ROCKVILLE, Md. and SUZHOU, China, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”), a global, commercial stage, integrated [...]
Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference
01/12/2025
BOSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today [...]

Pages